Ikena Oncology Price to Book Ratio 2021-2025 | IMA
Historical price to book ratio values for Ikena Oncology (IMA) over the last 10 years. The current price to book ratio for Ikena Oncology as of July 31, 2025 is 0.53.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Ikena Oncology Price/Book Ratio Historical Data |
| Date |
Stock Price |
Book Value per Share |
Price to Book Ratio |
| 2025-07-31 |
17.90 |
|
7.30 |
| 2025-03-31 |
15.36 |
$2.45 |
6.27 |
| 2024-12-31 |
19.68 |
$2.61 |
7.54 |
| 2024-09-30 |
20.76 |
$2.78 |
7.46 |
| 2024-06-30 |
19.80 |
$2.96 |
6.69 |
| 2024-03-31 |
17.04 |
$3.22 |
5.29 |
| 2023-12-31 |
23.64 |
$3.52 |
6.72 |
| 2023-09-30 |
51.96 |
$3.52 |
14.75 |
| 2023-06-30 |
78.72 |
$3.70 |
21.25 |
| 2023-03-31 |
41.40 |
$3.72 |
11.12 |
| 2022-12-31 |
31.92 |
$4.05 |
7.87 |
| 2022-09-30 |
42.60 |
$4.38 |
9.73 |
| 2022-06-30 |
53.16 |
$4.81 |
11.05 |
| 2022-03-31 |
73.20 |
$5.34 |
13.70 |
| 2021-12-31 |
150.48 |
$5.78 |
26.04 |
| 2021-09-30 |
151.44 |
$5.67 |
26.73 |
| 2021-06-30 |
168.48 |
$6.03 |
27.94 |
| 2021-03-31 |
339.00 |
$73.50 |
4.61 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.061B |
$0.009B |
|
Ikena Oncology Inc. is focused on developing cancer therapies targeting key signaling pathways which drive the formation and spread of cancer. The company's product candidates include IK-930, IK-175, IK-412 and IK-007, which are in clinical stage. Ikena Oncology Inc. is based in Boston, United States.
|
